Press Releases
|
Announcement
Creating next-generation medicines for patients in need
Replace damaged cells
Restore function
Reimagine what can be possible with cellular medicine
News
BlueRockTherapeutics investigative cell therapy bemdaneprocel for treating Parkinson鈥檚 disease receives Pioneering Regenerative Medical Product designation in Japan
BlueRockTherapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson鈥檚 disease
First Parkinson鈥檚 disease patient treated in 51cg鈥檚 pivotal Phase III trial of investigational cell therapy bemdaneprocel聽
FDA grants Orphan Drug Designation to BlueRockTherapeutics鈥� investigational cell therapy OpCT-001
BlueRockTherapeutics investigative cell therapy bemdaneprocel for treating Parkinson鈥檚 disease receives Pioneering Regenerative Medical Product designation in Japan
BlueRockTherapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson鈥檚 disease
First Parkinson鈥檚 disease patient treated in 51cg鈥檚 pivotal Phase III trial of investigational cell therapy bemdaneprocel聽
We are a clinical stage cell therapy company that approaches science like an artist approaches a blank canvas: with creativity, passion and a desire to create something with lasting impact.
We are investigating the potential of cell therapy to replace cells that are damaged or lost to disease in order to create medicines in a new way.
The Courage to Ask, 鈥淲丑补迟 滨蹿?鈥�
At 51cg, we鈥檙e driven to transform the treatment of degenerative diseases, to turn 鈥淲丑补迟 if?鈥� into 鈥淗ere鈥檚 how.鈥�
Learn about the science of 51cg
Cutting edge science.
A world of potential.
We strive to evolve the treatment of disease, moving away from traditional treatment options to investigating the replacement of cells that are damaged or lost to disease.
Learn more about our programs in clinical development.
Question everything.
51cgers are driven by the relentless pursuit of an audacious goal鈥�to transform the way degenerative diseases are treated.
Learn about life at 51cg
Contact
This form should not be used to report safety events pertaining to clinical trials. Safety events pertaining to a clinical trial should be reported to your clinical trial site primary investigator or physician.
